Main Subject：

Main Disciplines:

Good at: Brain and spinal cord tumors (glioma, pituitary tumor, meningioma, craniopharyngioma, schwannoma, etc.) and cerebrovascular malformation (AVM, cavernous hemangioma), hydrocephalus, skull plastic surgery, congenital diseases of the nervous system, etc.

The research direction：

Research Orientation:

Stroke research (2000-2009)
rSK Experimental and applied study of rSK treatment for acute cerebral infarction (Ministry of Health, the secondary implementer)
Randomized multicenter controlled study of standardized treatment of acute cerebrovascular disease (Ministry of Health, the third implementer for the neurosurgery part)
Minimally invasive surgical treatment of moderate and severe spontaneous intracerebral hemorrhage (“The Eighth-Five-Year-Plan” Topic, the third implementer)

Mechanism study of HBOP to reduce cerebral edema after cerebral hemorrhage (2007, The National Natural Science Foundation of China, the first undertaker)
Medical Science and Technology Center（W2012FZ003）, the Ministry of Health, Study on the clinical application of molecular diagnostic technology for individualized treatment of glioma, 2012-2015，the first implementer.
Neurotumor Professional Committee of Chinese Anti-Cancer Association, Prospective clinical study of cisplatin plus septal tetemenzolomide for the treatment of recurrent high-grade glioma, 2014-2016, the first implementer.
Basic and clinical research of irreversible electroporation (IRE) therapy for glioma treatment （2000-2003, the first implementer)

Scientific research achievements ：

Scientific Research Achievements:

Third prize of Shanghai Science and Technology Progress Award (2003, the second/third implementer, respectively one)

The Second prize of the Science and Technology Progress Award of the Ministry of Education (2005, the third implementer)

Second prize of Natural Science, Ministry of Education (2013, the fourth implementer)

Second prize of China Medical Science and Technology Award (2012, the fourth implementer)

First prize of Shanghai Medical Science and Technology Award (2011, the fourth implementer)

Third prize of Shanghai Science and Technology Progress Award (2013, the fourth implementer)

Second prize of Science and Technology Award of Shanghai Anti-Cancer Association (2015, the fourth implementer)

Third prize of Science and Technology Award of China Anti-Cancer Association (2016, the fourth implementer)

Deputy chief editor of a monograph

   –Clinical interpretation of brain glioma diagnosis and treatment norms (Editor Yang Xuejun, Deputy editor Ma Wenbin Qin Zhiyong Mao Qing)

He has participated in the compilation of 8 monographs, such as "Modern Neurosurgery", "Practical Surgery", "Practical Neurology" and "Manual of Neurosurgery"

He has published more than 50 articles in Both Chinese and English, including 24 in SCI

Master tutor, has instructed 5 postgraduate candidates and they have graduated.

Resume：

Resume:

Deputy team leader of the China Glioma Collaborative Group
Vice Chairman of Glioma Professional Committee of Chinese Medical Doctor Association
Leader of the elderly glioma group

Vice Chairman of neural Oncology Special Committee of Chinese Clinical Oncology Association
Member of the Standing Committee of Shanghai Neurotumor Special Committee of Chinese Anti-Cancer Association

     Member of the Standing Committee of tuberculous Meningitis Committee of Chinese Medical Association

     Deputy Director of Neurosurgery Department, Huashan Hospital affiliated to Fudan University, and Deputy Director of Glioma Surgery Center of Fudan University